Jazz Pharmaceuticals
CA · 13 filings, 2025
What the money shows
JAZZ Pharmaceuticals reported $1.6M in federal lobbying for 2025 across 13 filings. The filings name 4 lobbying firms, led by JAZZ Pharmaceuticals and Tarplin DOWNS & YOUNG. The matched PAC file shows $8,000 to 0 lawmakers. The filing text lists 3 issue areas.
Sources: Senate LDA · FEC
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Pharmacy · Medicare/Medicaid
2Through these firms · 4
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews
4And its PAC funds these lawmakers · 2
No republicans on file.